NCT07684898 — Severe Hemophilia A trial site landscape

Public-registry site landscape for NCT07684898, a Severe Hemophilia A study sponsored by Hangzhou Gensciences Biopharmaceutical Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07684898 (registry record)
Sponsor	Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Condition(s)	Severe Hemophilia A
Phase	PHASE3
Listed sites	19
Site countries	China

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07684898 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.